PACS Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
1.4B
+0.5%
1.4B
+4.6%
1.4B
+1.0%
1.3B
+2.7%
1.3B
Cost of Revenue
1.2B
+10.2%
1.1B
+3.4%
1.0B
-0.7%
1.0B
-6.2%
1.1B
Gross Profit
243.8M
-29.5%
346.0M
+8.4%
319.2M
+7.0%
298.3M
+53.8%
194.0M
Operating Expenses
134.4M
-40.5%
225.9M
+0.6%
224.5M
+5.9%
212.0M
+86.8%
113.5M
R&D
0
0
0
0
0
SG&A
114.3M
+1.8%
112.3M
-1.0%
113.5M
+10.7%
102.5M
+2.2%
100.3M
Operating Income
109.3M
-8.9%
120.0M
+26.8%
94.7M
+9.8%
86.3M
+7.2%
80.5M
EBITDA
129.5M
-6.3%
138.1M
+25.5%
110.1M
+9.3%
100.7M
+7.5%
93.7M
Net Income
76.3M
-5.4%
80.7M
+34.9%
59.8M
+14.2%
52.3M
+2.7%
51.0M
EPS (Basic)
$0.48
-5.9%
$0.51
+34.2%
$0.38
+15.2%
$0.33
+0.0%
$0.33
EPS (Diluted)
$0.47
-6.0%
$0.50
+8.7%
$0.46
+43.8%
$0.32
+3.2%
$0.31
Shares (Diluted)
162.0M
-0.1%
162.1M
+24.5%
130.2M
-21.0%
164.7M
-0.5%
165.5M
PACS (PACS) โ€” Financials